{"id":"W2031403784","doi":"10.1097/jto.0b013e31815ba7d0","title":"Phase I Study of Two Different Schedules of Bortezomib and Pemetrexed in Advanced Solid Tumors with Emphasis on Non-small Cell Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"University of California, Davis","keywords":"Medicine; Pemetrexed; Internal medicine; Neutropenia; Tolerability; Lung cancer; Oncology; Progressive disease; Bortezomib; Toxicity; Gastroenterology; Surgery; Chemotherapy; Adverse effect; Multiple myeloma; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001650229,0.002089584,0.003865171,0.0007520004,0.000641998,0.001463267,0.001918102,0.001974375,0.004155713],"category_scores_gemma":[0.001402316,0.001163236,0.001933528,0.0008080928,0.001709362,0.001458899,0.0004557106,0.00543764,0.0009646947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001551326,"about_ca_system_score_gemma":0.0022111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002472992,"about_ca_topic_score_gemma":0.004159731,"domain_scores_codex":[0.9993777,0.000234113,0.00002480701,0.0001370337,0.00004525551,0.0001811991],"domain_scores_gemma":[0.9988016,0.0002247706,0.0001735672,0.0001446723,0.00005949198,0.0005958036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8548813,0.07765269,0.001221163,0.000343156,0.0009249311,0.00006454145,0.0002132426,0.003286507,0.02393189,0.0003226235,0.001662659,0.03549528],"study_design_scores_gemma":[0.5950361,0.3964092,0.00283845,0.00001690814,0.0003594,0.00007008684,0.00006440959,0.0007184603,0.002890607,0.0001917421,0.001375652,0.00002892864],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927536,0.001946463,0.0006586781,0.0004675424,0.0003000398,0.001615723,0.0009089857,0.00009169147,0.001257265],"genre_scores_gemma":[0.9861298,0.002436916,0.002147391,0.0006821402,0.000315622,0.003310484,0.00188131,0.00007213963,0.003024135],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004155713,"threshold_uncertainty_score":0.01390231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01833055488774541,"score_gpt":0.4664682977449494,"score_spread":0.448137742857204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}